Advertisement
Screener

Coeptis Therapeutics, Inc. Form D

Coeptis Therapeutics, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2021-10-12: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-03-12; Total offering amount $9,000,000.
  • 2021-07-28: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-03-12; Total offering amount $6,000,000.
  • 2021-03-24: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-03-12; Total offering amount $6,000,000.
  • 2021-02-25: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-02-12; Total offering amount $0.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2021-10-12
D/A
Rule 506(b)Equity2021-03-12$9,000,000$5,521,500$3,478,50042
2021-07-28
D/A
Rule 506(b)Equity2021-03-12$6,000,000$5,206,500$793,50039
2021-03-24Rule 506(b)Equity2021-03-12$6,000,000$171,000$5,829,0002
2021-02-25Rule 506(b)Equity2021-02-12$0$0$081